Literature DB >> 28249121

Roselle supplementation prevents nicotine-induced vascular endothelial dysfunction and remodelling in rats.

Lislivia Yiang-Nee Si1, Yusof Kamisah2, Anand Ramalingam1, Yi Cheng Lim1, Siti Balkis Budin1, Satirah Zainalabidin1.   

Abstract

Vascular endothelial dysfunction (VED) plays an important role in the initiation of cardiovascular diseases. Roselle, enriched with antioxidants, demonstrates high potential in alleviating hypertension. This study was undertaken to investigate the effects of roselle supplementation of VED and remodelling in a rodent model with prolonged nicotine administration. Male Sprague-Dawley rats (n = 6 per group) were administered with 0.6 mg/kg nicotine for 28 days to induce VED. The rats were given either aqueous roselle (100 mg/kg) or normal saline orally 30 min prior to nicotine injection daily. One additional group of rats served as control. Thoracic aorta was isolated from rats to measure vascular reactivity, vascular remodelling and oxidative stress. Roselle significantly lowered aortic sensitivity to phenylephrine-induced vasoconstriction (Endo-(+) Cmax = 234.5 ± 3.9%, Endo-(-) Cmax = 247.6 ± 5.2%) compared with untreated nicotine group (Endo-(+) Cmax = 264.5 ± 6.9%, Endo-(-) Cmax = 276.5 ± 6.8%). Roselle also improved aortic response to endothelium-dependent vasodilator, acetylcholine (Endo-(+) Rmax = 73.2 ± 2.1%, Endo-(-) Rmax = 26.2 ± 0.8%) compared to nicotine group (Endo-(+) Rmax = 57.8 ± 1.7%, Endo-(-) Rmax = 20.9 ± 0.8%). In addition, roselle prevented an increase in intimal media thickness and elastic lamellae proliferation to preserve vascular architecture. Moreover, we also observed a significantly lowered degree of oxidative stress in parallel with increased antioxidant enzymes in aortic tissues of the roselle-treated group. This study demonstrated that roselle prevents VED and remodelling, and as such it has high nutraceutical value as supplement to prevent cardiovascular diseases.

Entities:  

Keywords:  dysfonction endothéliale; endothelial dysfunction; hypertension; nicotine; oxidative stress; remodelage vasculaire; roselle; stress oxydatif; vascular remodelling

Mesh:

Substances:

Year:  2017        PMID: 28249121     DOI: 10.1139/apnm-2016-0506

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  6 in total

1.  Electronic cigarette exposure causes vascular endothelial dysfunction due to NADPH oxidase activation and eNOS uncoupling.

Authors:  Mohamed A El-Mahdy; Mohamed G Ewees; Mahmoud S Eid; Elsayed M Mahgoup; Sahar A Khaleel; Jay L Zweier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-01-28       Impact factor: 4.733

2.  Acute administration of nicotine induces transient elevation of blood pressure and increases myocardial infarct size in rats.

Authors:  Lifu Zhao; Wangde Dai; Juan Carreno; Jianru Shi; Michael T Kleinman; Robert A Kloner
Journal:  Heliyon       Date:  2020-11-16

3.  Resveratrol Supplementation Protects Against Nicotine-Induced Kidney Injury.

Authors:  Anand Ramalingam; Thulasiprevinnah Santhanathas; Shafreena Shaukat Ali; Satirah Zainalabidin
Journal:  Int J Environ Res Public Health       Date:  2019-11-12       Impact factor: 3.390

4.  Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats.

Authors:  Anand Ramalingam; Siti Balkis Budin; Norsyahida Mohd Fauzi; Rebecca H Ritchie; Satirah Zainalabidin
Journal:  Front Pharmacol       Date:  2019-12-12       Impact factor: 5.810

5.  Fenofibrate Prevents nicotine-induced Acute Kidney Injury: Possible Involvement of Endothelial Nitric Oxide Synthase.

Authors:  Vishal Arvind Chakkarwar; Pravin Kawtikwar
Journal:  Indian J Nephrol       Date:  2021-04-06

6.  Targeting mitochondrial reactive oxygen species-mediated oxidative stress attenuates nicotine-induced cardiac remodeling and dysfunction.

Authors:  Anand Ramalingam; Siti Balkis Budin; Norsyahida Mohd Fauzi; Rebecca H Ritchie; Satirah Zainalabidin
Journal:  Sci Rep       Date:  2021-07-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.